These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 9307274)

  • 41. [TGF-beta signaling pathway in pancreatic cancer cells].
    Ijichi H
    Nihon Rinsho; 2004 Jul; 62(7):1241-8. PubMed ID: 15283139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
    Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
    Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
    Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
    Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
    Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
    Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.
    Reiss M; Santoro V; de Jonge RR; Vellucci VF
    Cell Growth Differ; 1997 Apr; 8(4):407-15. PubMed ID: 9101086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DPC4 gene in various tumor types.
    Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE
    Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
    Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
    Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Regulation by protein kinase C of TGF-beta 1 expression in cultured cells of breast adenocarcinoma].
    Guerrin M; Guilbaud N; Valette A
    Bull Cancer; 1992; 79(4):357-63. PubMed ID: 1421693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered regulation of protein disulfide isomerase in cells resistant to the growth-inhibitory effects of transforming growth factor beta 1.
    Sipes NJ; Miller DA; Bascom CC; Winkler JK; Matrisian LM; Moses HL
    Cell Growth Differ; 1990 May; 1(5):241-6. PubMed ID: 2085467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-suppressive pathways in pancreatic carcinoma.
    Rozenblum E; Schutte M; Goggins M; Hahn SA; Panzer S; Zahurak M; Goodman SN; Sohn TA; Hruban RH; Yeo CJ; Kern SE
    Cancer Res; 1997 May; 57(9):1731-4. PubMed ID: 9135016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis.
    Ramachandra M; Atencio I; Rahman A; Vaillancourt M; Zou A; Avanzini J; Wills K; Bookstein R; Shabram P
    Cancer Res; 2002 Nov; 62(21):6045-51. PubMed ID: 12414627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.
    Schwarte-Waldhoff I; Volpert OV; Bouck NP; Sipos B; Hahn SA; Klein-Scory S; Lüttges J; Klöppel G; Graeven U; Eilert-Micus C; Hintelmann A; Schmiegel W
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9624-9. PubMed ID: 10944227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
    Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
    J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative regulation of gene expression by TGF-beta.
    Matrisian LM; Ganser GL; Kerr LD; Pelton RW; Wood LD
    Mol Reprod Dev; 1992 Jun; 32(2):111-20. PubMed ID: 1637549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor beta 1-mediated induction of junB is selectively inhibited by expression of Ad.12-E1A.
    Coussens LM; Yokoyama K; Chiu R
    J Cell Physiol; 1994 Sep; 160(3):435-44. PubMed ID: 8077281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
    Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
    Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
    Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.